Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%

Clinical trial NCT01310127 · COMPLETED

Trial details

NCT number: NCT01310127
Sponsor: Toyos Clinic
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Inflammation Pseudophakia

Start date: 2010-11-01
Primary completion: 2011-04-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.